|
1
|
Schrader AJ, Sevinc S, Olbert PJ, Hegele
A, Varga Z and Hofmann R: Gender-specific characteristics and
survival of renal cell carcinoma. Urologe A. 47(1182): 1184–1186.
2008.(In German).
|
|
2
|
Tamaskar I, Choueiri TK, Sercia L, Rini B,
Bukowski R and Zhou M: Differential expression of caveolin-1 in
renal neoplasms. Cancer. 110:776–782. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ljungberg B, Hanbury DC, Kuczyk MA,
Merseburger AS, Mulders PF, Patard JJ and Sinescu IC: European
Association of Urology Guideline Group for renal cell carcinoma:
Renal cell carcinoma guideline. Eur Urol. 51:1502–1510. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Escudier B, Eisen T, Stadler WM, Szczylik
C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA,
et al: TARGET Study Group: Sorafenib in advanced clear-cell
renal-cell carcinoma. N Engl J Med. 356:125–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Motzer RJ, Hutson TE, Tomczak P,
Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik
C, Kim ST, et al: Sunitinib versus interferon alfa in metastatic
renal-cell carcinoma. N Engl J Med. 356:115–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu K, Xu L, Zhang L, Lin Z and Hou J: High
Jagged1 expression predicts poor outcome in clear cell renal cell
carcinoma. Jpn J Clin Oncol. 41:411–416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Curry SC, Carlton MW and Raschke RA:
Prevention of fetal and maternal cyanide toxicity from
nitroprusside with coinfusion of sodium thiosulfate in gravid ewes.
Anesth Analg. 84:1121–1126. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Honkanen RE: Cantharidin, another natural
toxin that inhibits the activity of serine/threonine protein
phosphatases types 1 and 2A. FEBS Lett. 330:283–286. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clarke PR, Hoffmann I, Draetta G and
Karsenti E: Dephosphorylation of cdc25-C by a type-2A protein
phosphatase: Specific regulation during the cell cycle in Xenopus
egg extracts. Mol Biol Cell. 4:397–411. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen YN, Chen JC, Yin SC, Wang GS, Tsauer
W, Hsu SF and Hsu SL: Effector mechanisms of norcantharidin-induced
mitotic arrest and apoptosis in human hepatoma cells. Int J Cancer.
100:158–165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kok SH, Cheng SJ, Hong CY, Lee JJ, Lin SK,
Kuo YS, Chiang CP and Kuo MY: Norcantharidin-induced apoptosis in
oral cancer cells is associated with an increase of proapoptotic to
antiapoptotic protein ratio. Cancer Lett. 217:43–52. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huan SK, Lee HH, Liu DZ, Wu CC and Wang
CC: Cantharidin-induced cytotoxicity and cyclooxygenase 2
expression in human bladder carcinoma cell line. Toxicology.
223:136–143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Williams LA, Moller W, Merisor E, Kraus W
and Rosner H: In vitro anti-proliferation/cytotoxic activity of
cantharidin (Spanish Fly) and related derivatives. West Indian Med
J. 52:10–13. 2003.PubMed/NCBI
|
|
14
|
Yi SN, Wass J, Vincent P and Iland H:
Inhibitory effect of norcantharidin on K562 human myeloid leukemia
cells in vitro. Leuk Res. 15:883–886. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weng AP and Aster JC: Multiple niches for
Notch in cancer: Context is everything. Curr Opin Genet Dev.
14:48–54. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qi R, An H, Yu Y, Zhang M, Liu S, Xu H,
Guo Z, Cheng T and Cao X: Notch1 signaling inhibits growth of human
hepatocellular carcinoma through induction of cell cycle arrest and
apoptosis. Cancer Res. 63:8323–8329. 2003.PubMed/NCBI
|
|
18
|
Ridgway J, Zhang G, Wu Y, Stawicki S,
Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I,
et al: Inhibition of Dll4 signalling inhibits tumour growth by
deregulating angiogenesis. Nature. 444:1083–1087. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng Q, Li S, Chepeha DB, Giordano TJ, Li
J, Zhang H, Polverini PJ, Nor J, Kitajewski J and Wang CY:
Crosstalk between tumor and endothelial cells promotes tumor
angiogenesis by MAPK activation of Notch signaling. Cancer Cell.
8:13–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sjölund J, Johansson M, Manna S, Norin C,
Pietras A, Beckman S, Nilsson E, Ljungberg B and Axelson H:
Suppression of renal cell carcinoma growth by inhibition of Notch
signaling in vitro and in vivo. J Clin Invest. 118:217–228. 2008.
View Article : Google Scholar : PubMed/NCBI
|
